rs2066805

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_007315.4(STAT1):​c.633+42A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0271 in 1,585,260 control chromosomes in the GnomAD database, including 1,616 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.029 ( 177 hom., cov: 32)
Exomes 𝑓: 0.027 ( 1439 hom. )

Consequence

STAT1
NM_007315.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.907

Publications

5 publications found
Variant links:
Genes affected
STAT1 (HGNC:11362): (signal transducer and activator of transcription 1) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]
STAT1 Gene-Disease associations (from GenCC):
  • autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, Orphanet
  • immunodeficiency 31B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-190998175-T-C is Benign according to our data. Variant chr2-190998175-T-C is described in ClinVar as Benign. ClinVar VariationId is 2628271.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STAT1NM_007315.4 linkc.633+42A>G intron_variant Intron 8 of 24 ENST00000361099.8 NP_009330.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STAT1ENST00000361099.8 linkc.633+42A>G intron_variant Intron 8 of 24 1 NM_007315.4 ENSP00000354394.4

Frequencies

GnomAD3 genomes
AF:
0.0288
AC:
4388
AN:
152214
Hom.:
175
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0141
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.0291
Gnomad EAS
AF:
0.0634
Gnomad SAS
AF:
0.0450
Gnomad FIN
AF:
0.0104
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0183
Gnomad OTH
AF:
0.0297
GnomAD2 exomes
AF:
0.0515
AC:
12896
AN:
250246
AF XY:
0.0454
show subpopulations
Gnomad AFR exome
AF:
0.0133
Gnomad AMR exome
AF:
0.209
Gnomad ASJ exome
AF:
0.0307
Gnomad EAS exome
AF:
0.0651
Gnomad FIN exome
AF:
0.0109
Gnomad NFE exome
AF:
0.0195
Gnomad OTH exome
AF:
0.0449
GnomAD4 exome
AF:
0.0269
AC:
38584
AN:
1432928
Hom.:
1439
Cov.:
26
AF XY:
0.0267
AC XY:
19106
AN XY:
715034
show subpopulations
African (AFR)
AF:
0.0108
AC:
356
AN:
32878
American (AMR)
AF:
0.198
AC:
8815
AN:
44622
Ashkenazi Jewish (ASJ)
AF:
0.0295
AC:
766
AN:
25950
East Asian (EAS)
AF:
0.0500
AC:
1978
AN:
39538
South Asian (SAS)
AF:
0.0425
AC:
3641
AN:
85634
European-Finnish (FIN)
AF:
0.0113
AC:
597
AN:
52892
Middle Eastern (MID)
AF:
0.0298
AC:
169
AN:
5666
European-Non Finnish (NFE)
AF:
0.0187
AC:
20305
AN:
1086252
Other (OTH)
AF:
0.0329
AC:
1957
AN:
59496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
2007
4014
6022
8029
10036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0288
AC:
4394
AN:
152332
Hom.:
177
Cov.:
32
AF XY:
0.0294
AC XY:
2190
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0141
AC:
587
AN:
41572
American (AMR)
AF:
0.114
AC:
1737
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
101
AN:
3472
East Asian (EAS)
AF:
0.0630
AC:
327
AN:
5194
South Asian (SAS)
AF:
0.0448
AC:
216
AN:
4820
European-Finnish (FIN)
AF:
0.0104
AC:
111
AN:
10624
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0183
AC:
1248
AN:
68032
Other (OTH)
AF:
0.0294
AC:
62
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
198
396
593
791
989
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0298
Hom.:
46
Bravo
AF:
0.0375
Asia WGS
AF:
0.0690
AC:
240
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 24% of patients studied by a panel of primary immunodeficiencies. Number of patients: 23. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.73
DANN
Benign
0.58
PhyloP100
-0.91
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2066805; hg19: chr2-191862901; API